NCT00279721View on ClinicalTrials.gov

Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Thyroid Neoplasms
Interventions
PROCEDURE

IMRT

All Listed Sponsors
lead

Alberta Health services

OTHER

NCT00279721 - Phase II Study of IMRT With SIB as Adjuvant Treatment for High Risk Resected Well-differentiated Thyroid Cancer. | Biotech Hunter | Biotech Hunter